GLP-1 & Medical Weight Loss Claim Audit.
AuditGPT reviews public-facing weight-loss claims, medication language, outcome promises, testimonial framing, and AI answer surfaces so clinics can see what is supported, what is overstated, and what should be rewritten.
Not legal advice. Not medical advice. Not regulatory certification. Claim language review only.
Example — what the free snapshot surfaces
High risk“Compounded semaglutide works the same as Ozempic.”
Why it matters
FDA has warned that compounded GLP-1 drugs are not FDA-approved and are not reviewed for safety, effectiveness, or quality. Claiming equivalence to an FDA-approved drug overstates what the public record supports.
Visible support
Compound contains semaglutide as active ingredient — public record supports this.
Support missing
No public device citation or FDA equivalence statement found. FDA guidance contradicts equivalence framing for compounded products.
Safer rewrite preview
“Medically supervised weight-management consultation. Treatment options, including medication-assisted approaches, reviewed by a licensed provider.”
Free snapshot surfaces 3 findings like this. The $497 audit includes all claims, proof-gap table, AI Answer Reality Receipt, and safer rewrites for every flagged phrase.
Unlock full Claim Exposure Audit — $497Why GLP-1 pages are high-risk
The fastest-growing claim surface in medical aesthetics.
Every med-spa and wellness clinic adding GLP-1 or medical weight loss services is creating new website pages, landing pages, and ad copy this year — most of it written before anyone checked the claim language against visible support.
GLP-1 advertising sits at the intersection of three active enforcement areas: FTC outcome claim rules, FDA medication advertising standards, and emerging compound pharmacy restrictions. That combination means a single poorly worded sentence — "lose up to 30 pounds guaranteed" — creates exposure in multiple directions simultaneously.
FTC active review
Weight loss advertising is a priority enforcement category. The FTC specifically scrutinizes numeric outcome claims, before/after framing, and testimonial use.
FDA compound status
Compounded semaglutide and tirzepatide have fluctuating FDA regulatory status. Advertising language needs to reflect current status accurately.
AI answer distortion
AI engines synthesize your public pages. If your page says "FDA approved" incorrectly, that error is repeated in AI-generated answers to patient questions.
Platform ad policy
Google and Meta have specific restrictions on advertising weight loss medications. Website claim language can affect ad account status.
Common risky phrases
Language AuditGPT flags on GLP-1 pages.
"Lose 20 pounds in 30 days"
Numeric outcome without cohort data or qualification criteria
"No side effects"
All GLP-1 medications have documented side effect profiles. This is directly contradicted by prescribing information.
"Safe for everyone"
GLP-1 medications have contraindications, require prescriber evaluation, and are not appropriate for all patients.
"FDA approved for weight loss"
Applies only to specific medications and specific indications. Compound semaglutide does not carry the same approval.
"Clinically proven results"
Requires a named study, journal, or trial. Without citation, this is unsupported marketing language.
"Doctor recommended"
Recommendation claims require attribution — which doctor, for which patients, in what context.
"Compounded semaglutide"
FDA has made compounding status of GLP-1 medications an active enforcement area. Advertising compound medications carries specific risk.
"Before/after" transformation framing
FTC requires clear disclosure of typical vs. atypical results. Celebrity-style transformation framing triggers scrutiny.
"Anti-aging weight loss"
Combines two high-risk claim categories without evidence for either.
"100% natural / no drugs"
If semaglutide or tirzepatide is prescribed, the "no drugs" framing is directly false.
What the $497 audit includes
Seven claim categories reviewed on every GLP-1 page.
Medication language
Whether semaglutide, tirzepatide, or compound medication names are used accurately and with appropriate prescribing context.
Outcome claims
Numeric weight loss promises, timelines, and average result claims checked against visible cohort data.
Testimonial framing
Before/after photos, transformation language, and patient story framing reviewed for FTC-aligned disclosure.
FDA approval wording
"FDA approved" vs. "FDA authorized" vs. compound medication status — each is distinct and must be stated accurately.
Side effect disclosure
Whether contraindications, side effect profiles, and prescriber-required evaluation are visible near the offer.
AI answer surfaces
How ChatGPT, Perplexity, and Google AI Overviews describe your weight loss program — including whether they repeat inaccurate claims.
Competitor claim comparison
How your claims compare to peer clinic language in AI-generated answers.
Offer stack
Start free. Graduate through the system.
Free GLP-1 Claim Snapshot
$0 one-time
Submit your URL. We surface the top 3 claim exposures on your weight loss or GLP-1 pages — outcome language, medication wording, or AI answer distortion.
Run Free SnapshotGLP-1 Claim Exposure Audit
$497 one-time
Full claim inventory of your weight loss pages. Every flagged claim gets a risk label, evidence map, safer rewrite, and proof requirement. AI Answer Reality Receipt included.
Get the $497 AuditClaim Cleanup Record
$1,997 one-time
Done-for-you: safer rewrites executed across your weight loss and GLP-1 pages. Final Claim Cleanup Record PDF — a structured record of what changed, why, and what public support now backs each claim.
Book Claim Cleanup RecordQuestions
What to know before you run a snapshot.
Claim-reviewed weight loss marketing. Before your next launch.
AuditGPT does not provide medical, legal, regulatory, clinical, or prescribing advice. It does not certify compliance or guarantee ad approvals, rankings, AI answers, or revenue outcomes. It reviews public-facing claims against visible support and identifies proof gaps, risky language, and safer rewrite options.